Tag: genetic toxicology testing market share

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

How is the Genetic Toxicology Testing Market size predicted to change over the forecast window of 2026–2035?

The genetic toxicology testing market has experienced significant expansion recently. Projections indicate it will increase from $1.8 billion in 2025 to $1.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. Factors such as regulatory safety requirements, an increase in pharmaceutical R&D, the early integration of in vivo testing, monitoring of industrial chemicals, and environmental health studies are considered contributors to its historical growth.

The genetic toxicology testing market size is anticipated to experience substantial growth over the coming years. It is projected to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion during the forecast period is primarily driven by the move towards alternative testing methods, more stringent regulatory frameworks, advancements in biologics development, the need for safer chemicals, and the increasing scope of toxicogenomics. Noteworthy trends for the same period encompass a heightened application of genotoxicity testing in drug development, the increasing adoption of in vitro genetic toxicology assays, an intensifying regulatory focus on chemical safety testing, the broadening of environmental genotoxicity assessment, and a greater demand from pharmaceutical safety studies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

Which Drivers Are Contributing To The Expansion Of The Genetic Toxicology Testing Market?

The rising need for individualized healthcare is anticipated to drive the expansion of the genetic toxicology testing market in the future. This medical approach, known as personalized medicine, customizes healthcare choices, procedures, treatments, and goods for each patient, considering their anticipated reaction or likelihood of disease. The personalized medicine market has seen significant positive momentum, attributed to advancements in genetics, a deeper comprehension of diseases, the presence of diagnostic tools reliant on biomarkers, healthcare programs focused on value, and its incorporation into both clinical settings and research. Through offering crucial data on genetic differences, vulnerability to agents causing genetic damage, and how patients respond to treatments, genetic toxicology testing plays a vital role in personalized medicine. Illustratively, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 novel personalized medicines for individuals with rare disease patients, an increase from six approvals in 2022. Consequently, the growing requirement for personalized medicine fuels the genetic toxicology testing market.

What Segment Classifications Make Up The Genetic Toxicology Testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Testing Method: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent)

Which Competitive Trends Are Impacting The Structure Of The Genetic Toxicology Testing Market?

Leading companies within the genetic toxicology testing market are concentrating on creating innovative drug screening platforms, including high throughput transcriptomics, to enhance the precision and efficiency of identifying potential genetic toxins. High throughput transcriptomics signifies a technology-driven approach that enables the extensive measurement of gene expression (the transcriptome) across many samples in parallel, typically utilizing methods like RNA sequencing (RNA-seq). This allows researchers to assess, in a high-throughput manner, how various compounds (e.g., drugs or chemicals) perturb global cellular gene expression, which assists in predicting toxicological effects, modes of action (MOA), and potential genotoxicity. For instance, in September 2024, Toxys, a Netherlands-based biotech company specializing in in vitro toxicology solutions, launched MutaTracker. This mammalian cell-based mutagenicity and genotoxicity assay integrates its established ToxTracker reporter system with error-corrected single molecule mutation sequencing (SMM seq). This platform facilitates ultra-sensitive detection of point mutations, even those as rare as 1 in 107 bases, and provides detailed insight into the genotoxic mode of action, thereby improving accuracy and reducing false positives compared to traditional cytogenetic assays.

Which Leading Companies Dominate The Genetic Toxicology Testing Market Share?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2026, By The Business Research Company

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Genetic Toxicology Testing Market Today And What Is Its Future Size?

In the recent past, the genetic toxicology testing market has witnessed a potent expansion. Forecasts predict an increase from $1.63 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this significant growth during the historic period include intensifying public health issues, the effect of escalating globalization, the deepening emphasis on personalized medicine, the augmenting requirement for strict testing solutions and the rise in the number of drugs.

Projection suggests a robust expansion in the genetic toxicology testing market, which is slated to reach $2.56 billion in 2029 with a 9.2% compound annual growth rate (CAGR). This anticipated growth during the forecast period is attributed to escalating demand for testing innovative food products, increasing concerns over potential risks involved, disturbing health and environmental issues, stricter regulatory examination, a shift towards in vitro testing procedures, and emergence of high-throughput screening systems. Key trends that will shape the forecast period include the development in precision medicine and toxicogenomics, improved risk communication, novel methods of genetic toxicology testing, advancements in risk assessment methodologies, integration of omics technologies, and progression in genomics and molecular biology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What External And Internal Drivers Are Influencing The Genetic Toxicology Testing Market?

The genetic toxicology testing market’s growth is projected to accelerate due to the growing demand for personalised medicine. This method of medicine customises healthcare decisions, practices, interventions, and products to individual patients based on their predicted responses or risk factors for disease. The expansion of the personal medicine market has been positively impacted by genetic advancements, enhanced comprehension of diseases, the existence of biomarker-based diagnostics, incorporation into clinical practise and research, as well as value-based healthcare initiatives. Genetic toxicology testing plays a crucial role in personalised medicine by offering critical data about genetic variability, susceptibility to genotoxic agents, and treatment responses. For example, information from the Personalized Medicine Coalition, a non-profit organisation based in the US, shows that in February 2024, the FDA approved 16 new personalised medications for patients with rare diseases, a noticeable increase from six in 2022. Hence, the increasing necessity for personalised medicine is fuelling the genetic toxicology market’s growth.

How Is The Genetic Toxicology Testing Market Categorized Across Applications And Types?

The genetic toxicology testingmarket covered in this report is segmented –

1) By Type: In Vitro; In Vivo

2) By Product: Services; Reagents And Consumables; Assays

3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications

Subsegments:

1) By In Vitro: Ames Test; Micronucleus Assay; Comet Assay; Chromosomal Aberration Test; Cell Transformation Assay; Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent); Comet Assay (In Vivo); Bone Marrow Chromosomal Aberration Test; Dominant Lethal Test (Rodent); Other In Vivo Methods

How Are Market Trends Influencing Competition In The Genetic Toxicology Testing Market?

Key players in the genetic toxicology testing market are concentrating on creating novel drug screening platforms like phenotypic drug screening. This enhances precision and efficacy in spotting possible genetic toxins. Phenotypic drug screening is a technique utilized in drug discovery where compounds are examined based on their capacity to yield a distinct cellular or physiological reaction in a whole organism or a related cell system. Take for example, in August 2022, Creative Biogene, a biotechnology organization based in the US, unveiled zebrafish disease models to aid drug discovery and toxicology research. These models are crafted to simulate human genetic diseases in zebrafish, bestowing insights into disease pathogenesis, drug discovery, and toxicology. The zebrafish models by Creative Biogene provide a worthwhile platform for drug toxicity assessment, foreseeing the safety of new compounds, and backing the drug development procedure.

Who Are The Global Leaders Steering The Genetic Toxicology Testing Market Forward?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Are The Emerging Regional Trends Driving The Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2025, By The Business Research Company

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Direct To Consumer Dtc Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

In Vitro Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Genetic Toxicology Testing Market By 2029?

The genetic toxicology testing market size has seen rapid growth in recent years. It is forecast to increase from $1.63 billion in 2024 to $1.8 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the historical period is attributable to factors such as rising public health crises, increasing globalization, a greater focus on personalized medicine, an escalating demand for rigorous testing solutions, and a growing number of new drugs.

The genetic toxicology testing market is poised for significant expansion in the coming years, with its size anticipated to reach $2.56 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth throughout the forecast period stems from several key factors, including the increasing demand for novel food testing, growing apprehension regarding potential risks, escalating environmental and health concerns, heightened regulatory scrutiny, the expanded adoption of in vitro testing methods, and the emergence of high-throughput screening platforms. Key trends shaping this market during the forecast timeframe encompass advancements in precision medicine and toxicogenomics, an emphasis on comprehensive risk communication, evolution in genetic toxicology testing methodologies, progress in risk assessment methodologies, the incorporation of omics technologies, and breakthroughs in genomics and molecular biology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Are The Top Growth Drivers Impacting The Genetic Toxicology Testing Market Outlook?

The future expansion of the genetic toxicology testing market is anticipated due to the rising need for personalized medicine. This medical approach involves customizing healthcare choices, methods, treatments, and goods for each patient, considering their anticipated reaction or vulnerability to illness. The personalized medicine market has seen significant positive development, driven by advancements in genetics, enhanced disease comprehension, accessible diagnostic tools relying on biomarkers, value-focused healthcare programs, and its incorporation into clinical settings and research. Genetic toxicology testing aids personalized medicine by offering crucial data concerning genetic variations, vulnerability to genotoxic substances, and how patients respond to treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized medicines for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing requirement for personalized medicine is a key impetus for the genetic toxicology testing market.

How Is The Genetic Toxicology Testing Market Segmented?

The genetic toxicology testingmarket covered in this report is segmented –

1) By Type: In Vitro; In Vivo

2) By Product: Services; Reagents And Consumables; Assays

3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications

Subsegments:

1) By In Vitro: Ames Test; Micronucleus Assay; Comet Assay; Chromosomal Aberration Test; Cell Transformation Assay; Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent); Comet Assay (In Vivo); Bone Marrow Chromosomal Aberration Test; Dominant Lethal Test (Rodent); Other In Vivo Methods

What Trends Are Expected To Drive The Genetic Toxicology Testing Market?

Companies operating in the genetic toxicology testing market are focusing on the creation of innovative drug screening platforms, such as phenotypic drug screening, to improve the accuracy and efficiency in identifying potential genetic toxins. Phenotypic drug screening is an approach utilized in drug discovery where compounds are assessed based on their ability to produce a specific cellular or physiological response in a whole organism or a relevant cell system. For instance, in August 2022, Creative Biogene, a US-based biotechnology company, launched zebrafish disease models to aid drug discovery and toxicology research. These models are designed to mimic human genetic diseases in zebrafish, offering insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models provide a valuable platform for evaluating drug toxicity, predicting the safety of new compounds, and supporting the drug development process.

Which Major Firms Are Strengthening Their Position In The Genetic Toxicology Testing Industry?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genetic Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2025, By The Business Research Company

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Direct To Consumer Dtc Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

In Vitro Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the genetic toxicology testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Genetic Toxicology Testing Market Size From 2025 to 2034?

In recent years, the market size for genetic toxicology testing has witnessed substantial growth. The market is projected to expand from $1.63 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The significant growth during the historic period is due to several factors such as escalating public health emergencies, escalating globalization, heightened emphasis on personalized treatment, surging demand for rigorous testing solutions, and an upsurge in the number of drugs.

In the forthcoming years, swift expansion is predicted for the genetic toxicology testing market, expected to reach $2.64 billion by 2029 demonstrating a 10.0% compound annual growth rate (CAGR). Several factors are contributing to this increase during the forecast period such as increased testing of innovative foods, growing apprehension concerning potential hazards, amplified environmental and health fears, heightened regulatory investigation, a surge in the usage of in vitro testing techniques, and the emergence of high-throughput screening systems. Notable trends throughout this period include the evolution in precision medicine and toxicogenomics, wide-ranging risk dialogue, genetic toxicology testing methodologies, maturing risk evaluation methodologies, integration of omics technologies, and progression in genomics and molecular biology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What are the Fundamental Drivers and Innovations Shaping the Genetic Toxicology Testing Market?

The genetic toxicology testing market is predicted to flourish with the rising demand for personalized medicine. This medical model, also known as personalized medicine, tailors healthcare strategies, practices, interventions, and products to match individual patients based on their anticipated response or disease risk. The growth of the personalized medicine market has been fueled by genetic advancements, a deeper comprehension of diseases, access to biomarker-based diagnostics, value-driven healthcare initiatives, and incorporation into clinical practice and research. Genetic toxicology testing plays a vital role in personalized medicine by offering critical data about genetic variability, susceptibility to genotoxic agents, and responsiveness to treatment. For example, the Personalized Medicine Coalition, a non-profit organization based in the United States, reported that in February 2024, 16 new personalized medicines were approved for patients with rare diseases, marking an increase from six approval in 2022. Hence, the escalating demand for personalized medicine stimulates the growth of the genetic toxicology testing market.

What Segment Types Define the Genetic Toxicology Testing Market Structure?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Which Regions Are Driving the Next Phase of the Genetic Toxicology Testing Market Growth?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Genetic Toxicology Testing Market?

In an effort to enhance the precision and efficiency of genetic toxin identification, leading corporations in the genetic toxicology testing market are concentrating on creating innovative drug screening platforms, one of which is phenotypic drug screening. This screening approach is utilized in drug discovery, with compounds being tested for their capacity to produce a specific physiological or cellular response within an organism or relevant cell system. An example of this advancement was seen in August 2022 when Creative Biogene, a biotechnology company based in the United States, introduced zebrafish disease models to assist in drug discovery and toxicology research. These models have been developed to replicate human genetic diseases in zebrafish, offering valuable insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models serve as a valuable resource for evaluating drug toxicity, ensuring the safety of innovative compounds, and facilitating the drug development procedure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Is the Definition of the Genetic Toxicology Testing Market?

Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Genetic Toxicology Testing Market?

The growth of the genetic toxicology testing market is anticipated to be driven by the escalating demand for personalized medicine. Personalized medicine, a healthcare model customizing decisions, practices, interventions, and products per individual patient based on their anticipated response or ailment risk, has seen a surge due to genetic advancements, enhanced comprehension of diseases, the accessibility of biomarker-grounded diagnostics, value-focused healthcare programs, and their amalgamation into clinical practice and study. Genetic toxicology testing plays a crucial role in personalized medicine by offering necessary data on genetic variability, response to treatment, and vulnerability to genotoxic agents. For example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024, that in 2023, the FDA approved 16 new personalized medicines for patients with rare diseases, up from six in 2022. Thus, the growing demand for personalized medicine is catalyzing the genetic toxicology testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

#What Are the Key Projections for the CAGR of the Genetic Toxicology Testing Market From 2025 to 2034?

The size of the genetic toxicology testing market has seen swift expansion in the past few years. The market value will elevate from $1.63 billion in 2024 to hit $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors such as escalating public health emergencies, proliferating globalization, a heightened emphasis on personalized healthcare, growing demand for thorough testing solutions, and an increase in drug numbers are responsible for the growth observed in the historic period.

Forecasted expansion of the genetic toxicology testing market is predicted to accelerate noticeably in the forthcoming years, with projections estimating a boom to $2.64 billion in 2029, boasting a compound annual growth rate (CAGR) of 10.0%. The projected growth in this upcoming period is mainly credited to the burgeoning demand for testing innovative foods, the escalating anxiety surrounding potential hazards, an increase in environmental and health concerns as well as growing regulatory oversight. Further impacting this market’s growth is the rising prominence of in vitro testing practices and the emergence of high-throughput screening frameworks. Notable emerging trends for the forecasted period encompass innovations in precision medicine and toxicogenomics, all-inclusive risk dialogue, methodologies in genetic toxicology testing, the evolution of risk assessment methodologies, the amalgamation of omics technologies and the progress in genomics and molecular biology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

What New Market Trends Are Reshaping theGenetic Toxicology Testing Market and Its Opportunities?

Leading firms in the genetic toxicology testing industry are focusing on the creation of innovative drug screening platforms such as phenotypic drug screening, which enhances precision and effectiveness in pinpointing potential genetic toxins. Phenotypic drug screening is a methodology utilized in drug discovery that tests compounds based on their capability to elicit a particular cellular or physiological reaction in an entire organism or relevant cell system. For illustration, Creative Biogene, an American biotech firm, debuted zebrafish disease models in August 2022 to bolster drug discovery and toxicology studies. These models simulate human genetic diseases in zebrafish, yielding insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models present a critical platform for gauging drug toxicity, predicting the safety of novel compounds, and aiding the drug development procedure.

Who Are the Leading Market Players Fueling Growth in the Genetic Toxicology Testing Market Trend?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

How is the Global Genetic Toxicology Testing Market Segemented?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Which Geographics are Influencing the Growth of the Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2025, By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the genetic toxicology testing market grown over the years?

In the recent past, the genetic toxicology testing market has experienced swift growth. The market size, which was valued at $1.63 billion in 2024, is predicted to rise to $1.8 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the growth during the historic period include ongoing public health crises, the rise in globalization, a shift towards personalized medicine, a surge in the demand for comprehensive testing solutions, and the growth in the number of drugs.

What Is the forecasted market size and growth rate for the genetic toxicology testing market?

Rapid expansion is anticipated in the genetic toxicology testing market in the coming years, with its value expected to swell to $2.64 billion by 2029 at a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this projected growth include an increase in testing for new food products, growing awareness of potential risks, environmental and health concerns, heightened regulatory scrutiny, a surge in the use of in vitro testing methods, and the emergence of high-throughput screening platforms. Forecast trends comprise advanced precision medicine and toxicogenomic, thorough risk communication, improved genetic toxicology testing methodologies, progress in risk assessment methods, the merging of omics technologies, and strides in genomics and molecular biology.

Get your genetic toxicology testing market report here!

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What are the major factors driving growth in the genetic toxicology testing market?

The genetic toxicology testing market’s growth is anticipated to be driven by the growing need for personalised medicine. This medical model enables tailored healthcare decisions, methods, interventions, and products based on the patient’s probable response or health risk. The market for personalized medicine has seen a positive surge due to genetic advancements, improved disease comprehension, the presence of diagnostics based on biomarkers, initiatives for value-based healthcare, and their integration into clinical practice and research. Genetic toxicology testing plays a pivotal role in personalised medicine by offering crucial data about genetic variability, vulnerability to genotoxic agents, and treatment response. For instance, 16 new personalized medicines for rare disease patients were approved by the FDA in 2023, a significant jump from only six in 2022, as per a report by the Personalized Medicine Coalition, a non-profit organization based in the US in February 2024. Hence, the escalating demand for personalised medicine is stimulating the growth of the genetic toxicology testing market.

What key areas define the segmentation of the global genetic toxicology testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What are the top market players propelling the growth of the genetic toxicology testing industry?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

What are the key trends shaping the future of the genetic toxicology testing market?

Pioneering businesses within the genetic toxicology testing market are concentrating their efforts on the creation of ground-breaking drug screening systems such as phenotypic drug screening to enhance precision and efficiency in spotting possible genetic toxins. Phenotypic drug screening is a technique that tests compounds according to their capacity to trigger a specific cellular or physiological response within an entire organism or a pertinent cell system. For example, in August 2022, Creative Biogene, a US biotechnology firm, introduced zebrafish disease models to aid drug discovery and toxicology research. These models are engineered to simulate human genetic disorders in zebrafish, shedding light on disease pathogenesis, drug discovery, and toxicology. The zebrafish models from Creative Biogene provide an essential platform for evaluating drug toxicity, forecasting the safety of fresh compounds, and aiding the drug development pathway.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

What regions are dominating the genetic toxicology testing market growth?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Genetic Toxicology Testing Market’s CAGR Through 2034?

In the past few years, the size of the genetic toxicology testing market has expanded substantially. It’s projected to increase from $1.63 billion in 2024 to $1.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.4%. The expansion seen in the historic period is fundamentally due to factors such as prevalent public health emergencies, heightened globalization, a greater emphasis on personalized medicine, a soaring demand for rigorous testing solutions, and arising quantity of drugs.

The market size for genetic toxicology testing is anticipated to witness exponential growth in the forthcoming years. It is projected to expand to $2.64 billion in 2029 with a compound annual growth rate (CAGR) of 10.0%. This anticipated growth within the forecast period could be attributed to the escalating demand for testing novel foods, heightened awareness about potential hazards, increasing health and environmental concerns, growing regulatory scrutiny, greater reliance on in vitro testing methods, and the emergence of high-throughput screening platforms. Notable trends during the forecast period encompass developments in precision medicine and toxicogenomic, extensive risk communication, methodologies used for genetic toxicology testing, progressive risk assessment methodologies, the application of omics technologies, and progress in genomics and molecular biology.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Genetic Toxicology Testing Market?

Personalized medicine’s growing demand is forecasted to fuel the expansion of the genetic toxicology testing market. Personalized medicine is a healthcare approach that personalizes healthcare decisions, practices, interventions, and products based on an individual’s anticipated response or disease risk. Factors like genetic breakthroughs, an improved understanding of diseases, the presence of diagnostics based on biomarkers, value-based healthcare programs, and integration into clinical practice and research have all contributed to a positive surge in the personalized medicine market. Genetic toxicology testing adds value to personalized medicine by offering crucial details about genetic variability, genotoxic agent susceptibility, and treatment response. For example, the Personalized Medicine Coalition, a US-based non-profit organization, revealed in February 2024 that the FDA approved 16 new personalized medicines for patients with rare diseases in 2023, an increase from six in 2022. Therefore, the escalating demand for personalized medicine is triggering the growth of the genetic toxicology testing market.

Get Your Free Sample of the Global Genetic Toxicology Testing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What Are the Leading Industry Players Dominating the Genetic Toxicology Testing Market?

Major companies operating in the genetic toxicology testing market are:

• Amazon.com Inc.

• Apple Inc.

• Target Corporation

• American Express

• Best Buy Co. Inc.

What Are the Latest Trends Leading to Disruption in the Genetic Toxicology Testing Market?

Major players in the genetic toxicology testing market are seeking to enhance accuracy and efficiency in identifying potential genetic toxins by creating novel drug screening platforms, such as phenotypic drug screening. This method involves testing compounds based on their capacity to elicit a specific cellular or physiological response in an entire organism or a relevant cell system, and is typically employed in drug discovery. Case in point, Creative Biogene, a biotechnology firm from the US, introduced zebrafish disease models in August 2022 to aid drug discovery and toxicology research. These models are engineered to simulate human genetic diseases in zebrafish, in order to gain insights into disease development, drug discovery, and toxicology. The zebrafish models from Creative Biogene prove to be a significant resource for gauging drug toxicity, projecting the safety of novel compounds, and to assist in drug development.

Get Instant Access to the Global Genetic Toxicology Testing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What Major Market Segments Define the Scope and Growth of the Genetic Toxicology Testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Which Regions Are Significant to the Growth of the Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Genetic Toxicology Testing Market and Its Key Components?

Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards.

Browse Through More Similar Reports By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: